Tech hooman uses AI to develop a custom cancer vaccine for dog

Australian tech entrepreneur Paul Conyngham’s love for his pet mutt Rosie, who is suffering from mast cell cancer, has led him to use AI to create what he claims is the very first personalized cancer vaccine for a dog.

How it started
Despite undergoing several rounds of chemotherapy and surgery, Rosie’s tumors persisted, leading Conyngham to leverage his background in data science and AI to find a radical alternative.

Using OpenAI’s ChatGPT and Google DeepMind’s AlphaFold, he identified mutated proteins in Rosie’s DNA that could serve as therapeutic targets.

When a drug manufacturer refused to supply the medicine, Conyngham collaborated with nanomedicine pioneer Professor Pall Thordarson at the University of New South Wales to develop a custom mRNA vaccine based on the AI-generated data.

The results
After receiving the injections, Rosie’s health has improved drastically. Most of her tumors have shrunk significantly, restoring her energy and quality of life.

This breakthrough highlights how medicine can be democratized through AI and mRNA technology, enabling rapid development of personalized treatments.

Conyngham posted on social media that many people are inquiring if Rosie’s treatment can be replicated for their dogs. He is exploring options with experts. His efforts may be one step closer to what all hoomans are dreaming of: an elixir of life for their pets.